All probes, except METAP1/2, showed significant signal differences between each cancer group (CRC, EGJC or GC) and the HC group (p-values ranging from < 0.0001 and < 0.05) (Fig. 3A). This evidence concerns the gene METAP1 and colorectal carcinoma.